CN109293948A - 一种水凝胶及其制备方法和应用 - Google Patents
一种水凝胶及其制备方法和应用 Download PDFInfo
- Publication number
- CN109293948A CN109293948A CN201810911671.1A CN201810911671A CN109293948A CN 109293948 A CN109293948 A CN 109293948A CN 201810911671 A CN201810911671 A CN 201810911671A CN 109293948 A CN109293948 A CN 109293948A
- Authority
- CN
- China
- Prior art keywords
- hydrogel
- quaternary ammonium
- ammonium salt
- sodium alginate
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 75
- 238000002360 preparation method Methods 0.000 title claims abstract description 52
- 239000000661 sodium alginate Substances 0.000 claims abstract description 70
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 70
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 70
- 229920001661 Chitosan Polymers 0.000 claims abstract description 69
- -1 aldehyde sodium alginate Chemical class 0.000 claims abstract description 53
- 238000006243 chemical reaction Methods 0.000 claims abstract description 45
- 229920002101 Chitin Polymers 0.000 claims abstract description 30
- 230000004048 modification Effects 0.000 claims abstract description 6
- 238000012986 modification Methods 0.000 claims abstract description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 4
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 4
- 239000011734 sodium Substances 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 30
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 28
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 28
- 125000001453 quaternary ammonium group Chemical class 0.000 claims description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 11
- 239000002262 Schiff base Substances 0.000 claims description 11
- 150000004753 Schiff bases Chemical class 0.000 claims description 11
- 239000003960 organic solvent Substances 0.000 claims description 8
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000178 monomer Substances 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- 239000002585 base Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000005660 chlorination reaction Methods 0.000 claims description 3
- PYYVNKGYKZGZHE-UHFFFAOYSA-N tributyl-[(4-ethenylphenyl)methyl]azanium Chemical compound CCCC[N+](CCCC)(CCCC)CC1=CC=C(C=C)C=C1 PYYVNKGYKZGZHE-UHFFFAOYSA-N 0.000 claims description 3
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 claims description 3
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 claims description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229960001126 alginic acid Drugs 0.000 claims 1
- 239000000783 alginic acid Substances 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 150000004781 alginic acids Chemical class 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 abstract description 8
- 230000003796 beauty Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 238000007493 shaping process Methods 0.000 abstract description 4
- 230000014759 maintenance of location Effects 0.000 abstract description 3
- 230000000474 nursing effect Effects 0.000 abstract description 3
- 230000008439 repair process Effects 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 60
- 206010052428 Wound Diseases 0.000 description 28
- 208000027418 Wounds and injury Diseases 0.000 description 28
- 235000019441 ethanol Nutrition 0.000 description 28
- 229960004756 ethanol Drugs 0.000 description 27
- 239000000499 gel Substances 0.000 description 25
- 239000012153 distilled water Substances 0.000 description 23
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000001914 filtration Methods 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 150000003384 small molecules Chemical class 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 230000001476 alcoholic effect Effects 0.000 description 10
- 239000012043 crude product Substances 0.000 description 10
- 230000001376 precipitating effect Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 238000004132 cross linking Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 7
- 238000001291 vacuum drying Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000003431 cross linking reagent Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000001408 fungistatic effect Effects 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 206010039509 Scab Diseases 0.000 description 3
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 3
- 125000003368 amide group Chemical group 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000010382 chemical cross-linking Methods 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000013014 purified material Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- BCPFWSWROVXGQA-UHFFFAOYSA-N 2-(2,4,4-trimethylpentan-2-yl)guanidine Chemical compound CC(C)(C)CC(C)(C)N=C(N)N BCPFWSWROVXGQA-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- FYPDLBRWCMAOHB-UHFFFAOYSA-N azane;chloromethane Chemical compound N.ClC FYPDLBRWCMAOHB-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229950000289 guanoctine Drugs 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000003113 alkalizing effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- IUPDXIXTYXNMFR-UHFFFAOYSA-N azane N,N-dimethylmethanamine hydrochloride Chemical compound [Cl-].[NH4+].CN(C)C IUPDXIXTYXNMFR-UHFFFAOYSA-N 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810911671.1A CN109293948B (zh) | 2018-08-10 | 2018-08-10 | 一种水凝胶及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810911671.1A CN109293948B (zh) | 2018-08-10 | 2018-08-10 | 一种水凝胶及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109293948A true CN109293948A (zh) | 2019-02-01 |
CN109293948B CN109293948B (zh) | 2021-01-26 |
Family
ID=65168173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810911671.1A Active CN109293948B (zh) | 2018-08-10 | 2018-08-10 | 一种水凝胶及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109293948B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111166931A (zh) * | 2020-01-21 | 2020-05-19 | 海南卓瑞生物医药有限公司 | 一种甲基丙烯酸丝胶/壳聚糖季铵盐水凝胶及其制备方法和应用 |
CN111269437A (zh) * | 2019-12-07 | 2020-06-12 | 中国海洋大学 | 一种兼具自愈性和黏附性的复合水凝胶的制备方法 |
CN111841299A (zh) * | 2019-04-29 | 2020-10-30 | 斯瑞有限责任公司 | 用于二氧化碳捕获、封存和利用的装置、设施、方法和组合物 |
CN112844328A (zh) * | 2020-12-24 | 2021-05-28 | 武汉理工大学 | 一种海藻酸钠/壳聚糖季铵盐磁性吸附凝胶球及其制备方法和应用 |
CN113069589A (zh) * | 2021-02-22 | 2021-07-06 | 中国科学院大学温州研究院(温州生物材料与工程研究所) | 一种可生物降解的抗菌止血海绵 |
CN113855852A (zh) * | 2021-09-28 | 2021-12-31 | 蓝科医美科学技术(吉林)有限公司 | 一种含有人参提取物的修复敷料及其制备方法 |
CN113876788A (zh) * | 2021-10-29 | 2022-01-04 | 武汉大学 | 红景天苷水凝胶制剂及其制备方法和应用 |
CN114230812A (zh) * | 2021-12-07 | 2022-03-25 | 广东省科学院健康医学研究所 | 一种功能性水凝胶及其制备方法和应用 |
CN114350034A (zh) * | 2021-12-01 | 2022-04-15 | 广东省科学院健康医学研究所 | 一种导电凝胶及其制备方法与应用 |
CN114748677A (zh) * | 2022-04-20 | 2022-07-15 | 华中科技大学 | 一种抗粘连的水凝胶粘合剂及制备方法、应用 |
CN115429931A (zh) * | 2022-10-24 | 2022-12-06 | 山东爱基康健康科技有限公司 | 一种包含外泌体的壳聚糖水凝胶敷料及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101343334A (zh) * | 2008-07-16 | 2009-01-14 | 深圳大学 | O-2′-羟丙基三甲基氯化铵壳聚糖的制备方法 |
CN101463144A (zh) * | 2009-01-12 | 2009-06-24 | 武汉理工大学 | 羟丙基壳聚糖/氧化海藻酸钠自交联抗菌水凝胶材料 |
CN105327388A (zh) * | 2015-12-07 | 2016-02-17 | 莫秀梅 | 一种医用粘合剂及其制备方法 |
-
2018
- 2018-08-10 CN CN201810911671.1A patent/CN109293948B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101343334A (zh) * | 2008-07-16 | 2009-01-14 | 深圳大学 | O-2′-羟丙基三甲基氯化铵壳聚糖的制备方法 |
CN101463144A (zh) * | 2009-01-12 | 2009-06-24 | 武汉理工大学 | 羟丙基壳聚糖/氧化海藻酸钠自交联抗菌水凝胶材料 |
CN105327388A (zh) * | 2015-12-07 | 2016-02-17 | 莫秀梅 | 一种医用粘合剂及其制备方法 |
Non-Patent Citations (3)
Title |
---|
QUNYING CHEN ET AL.: "Synthesis and characterization of quaternized b-chitin", 《CARBOHYDRATE RESEARCH》 * |
樊李红等: "羟丙基壳聚糖/氧化海藻酸钠水凝胶的制备及表征", 《武汉大学学报》 * |
温辉高等: "壳聚糖季铵盐/氧化魔芋葡甘露聚糖水凝胶的制备及性能", 《武汉大学学报》 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111841299A (zh) * | 2019-04-29 | 2020-10-30 | 斯瑞有限责任公司 | 用于二氧化碳捕获、封存和利用的装置、设施、方法和组合物 |
CN111269437A (zh) * | 2019-12-07 | 2020-06-12 | 中国海洋大学 | 一种兼具自愈性和黏附性的复合水凝胶的制备方法 |
CN111166931A (zh) * | 2020-01-21 | 2020-05-19 | 海南卓瑞生物医药有限公司 | 一种甲基丙烯酸丝胶/壳聚糖季铵盐水凝胶及其制备方法和应用 |
CN112844328A (zh) * | 2020-12-24 | 2021-05-28 | 武汉理工大学 | 一种海藻酸钠/壳聚糖季铵盐磁性吸附凝胶球及其制备方法和应用 |
CN112844328B (zh) * | 2020-12-24 | 2023-12-12 | 武汉理工大学 | 一种海藻酸钠/壳聚糖季铵盐磁性吸附凝胶球及其制备方法和应用 |
CN113069589A (zh) * | 2021-02-22 | 2021-07-06 | 中国科学院大学温州研究院(温州生物材料与工程研究所) | 一种可生物降解的抗菌止血海绵 |
CN113855852A (zh) * | 2021-09-28 | 2021-12-31 | 蓝科医美科学技术(吉林)有限公司 | 一种含有人参提取物的修复敷料及其制备方法 |
CN113855852B (zh) * | 2021-09-28 | 2022-06-28 | 蓝科医美科学技术(吉林)有限公司 | 一种含有人参提取物的修复敷料及其制备方法 |
CN113876788B (zh) * | 2021-10-29 | 2023-12-08 | 武汉大学 | 红景天苷水凝胶制剂及其制备方法和应用 |
CN113876788A (zh) * | 2021-10-29 | 2022-01-04 | 武汉大学 | 红景天苷水凝胶制剂及其制备方法和应用 |
CN114350034A (zh) * | 2021-12-01 | 2022-04-15 | 广东省科学院健康医学研究所 | 一种导电凝胶及其制备方法与应用 |
CN114350034B (zh) * | 2021-12-01 | 2023-03-31 | 广东省科学院健康医学研究所 | 一种导电凝胶及其制备方法与应用 |
CN114230812A (zh) * | 2021-12-07 | 2022-03-25 | 广东省科学院健康医学研究所 | 一种功能性水凝胶及其制备方法和应用 |
CN114748677A (zh) * | 2022-04-20 | 2022-07-15 | 华中科技大学 | 一种抗粘连的水凝胶粘合剂及制备方法、应用 |
CN115429931A (zh) * | 2022-10-24 | 2022-12-06 | 山东爱基康健康科技有限公司 | 一种包含外泌体的壳聚糖水凝胶敷料及其制备方法 |
CN115429931B (zh) * | 2022-10-24 | 2023-08-15 | 山东爱基康健康科技有限公司 | 一种包含外泌体的壳聚糖水凝胶敷料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN109293948B (zh) | 2021-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109293948A (zh) | 一种水凝胶及其制备方法和应用 | |
Morin-Crini et al. | Fundamentals and applications of chitosan | |
Khattak et al. | Applications of cellulose and chitin/chitosan derivatives and composites as antibacterial materials: current state and perspectives | |
Kundu et al. | Cellulose hydrogels: Green and sustainable soft biomaterials | |
Dave et al. | Natural polysaccharide-based hydrogels and nanomaterials: Recent trends and their applications | |
Rinaudo | Chitin and chitosan: Properties and applications | |
JP4066443B1 (ja) | 糖誘導体とその利用 | |
Zhuang et al. | Preparation of elastic and antibacterial chitosan–citric membranes with high oxygen barrier ability by in situ cross-linking | |
EP0020183B1 (en) | Poly-ion complex, process for its preparation and shaped articles prepared therefrom | |
JP2009221136A (ja) | 糖誘導体製剤 | |
CN108752501B (zh) | 一种含有机酸盐的壳聚糖季铵盐及其制备方法和应用 | |
CN109796606A (zh) | 一种基于多重动态化学键的自愈合水凝胶及其制备方法 | |
CN113444265A (zh) | 一种功能化二氧化钛抗菌水凝胶及其制备方法 | |
CN107383239A (zh) | 一种n‑吡啶脲基壳聚糖季铵盐及其制备方法和应用 | |
Kil’deeva et al. | Peculiarities of obtaining biocompatible films based on chitosan cross linked by genipin | |
Wang et al. | Formation of composite hydrogel of carboxymethyl konjac glucomannan/gelatin for sustained release of EGCG | |
Rahmani et al. | Preparation of self-healable nanocomposite hydrogel based on Gum Arabic/gelatin and graphene oxide: Study of drug delivery behavior | |
Pourjavadi et al. | Synthesis, characterization and swelling behavior of chitosan‐sucrose as a novel full‐polysaccharide superabsorbent hydrogel | |
CN100494223C (zh) | 季胺盐改性的壳聚糖亲核no供体的合成方法 | |
Taher et al. | Development of smart alginate/chitosan grafted microcapsules for colon site-specific drug delivery | |
Kumari et al. | Chemistry, biological activities, and uses of moringa gum | |
Rinauldo | Chitin and chitosan: Properties and applications | |
JPS6144084B2 (zh) | ||
CN104324372A (zh) | 新城疫弱毒苗o-2′-羟丙基三甲基氯化铵壳聚糖纳米粒缓释剂的制备方法 | |
CN102886061B (zh) | 碘化壳聚糖生物抗菌膜 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500 Patentee after: Institute of health medicine, Guangdong Academy of Sciences Address before: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500 Patentee before: GUANGDONG INSTITUTE OF MEDICAL INSTRUMENTS |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231206 Address after: No.10, shiliugang Road, Haizhu District, Guangzhou City, Guangdong Province 510000 Patentee after: Institute of biological and medical engineering, Guangdong Academy of Sciences Address before: No. 1307, Guangzhou Avenue middle, Tianhe District, Guangzhou, Guangdong 510500 Patentee before: Institute of health medicine, Guangdong Academy of Sciences |